Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1985 | 12-1984 | 12-1983 | 12-1982 | 12-1981 | |
| Sales | 2,918,700 | 3,109,200 | 3,033,700 | 2,962,711 | 2,773,205 |
| Cost of Goods | 1,077,600 | 1,128,400 | 1,103,200 | 1,129,094 | 1,083,734 |
| Gross Profit | 2,095,200 | 1,980,800 | 1,930,500 | 1,833,617 | 1,689,471 |
| Operating Expenses | 1,120,500 | 1,236,900 | 1,205,800 | 1,162,773 | 1,073,596 |
| Operating Income | 721,200 | 744,300 | 724,900 | 670,938 | 616,609 |
| Interest Expense | 0 | 43,100 | 33,500 | 26,690 | 22,174 |
| Other Income | 30,700 | 69,500 | 63,400 | 39,909 | 51,555 |
| Pre-tax Income | 751,900 | 770,700 | 754,800 | 684,157 | 645,990 |
| Income Tax | 258,300 | 280,500 | 297,400 | 272,329 | 271,512 |
| Net Income Continuous | 493,600 | 490,200 | 457,400 | 411,828 | 374,478 |
| Net Income Discontinuous | 24,000 | 0 | 0 | 0 | 0 |
| Net Income | $517,600 | $490,200 | $457,400 | $411,828 | $374,478 |
| EPS Basic Total Ops | 0.46 | 0.42 | 0.39 | 0.34 | 0.31 |
| EPS Basic Continuous Ops | 0.22 | 0.43 | 0.39 | 0.34 | 0.31 |
| EPS Basic Discontinuous Ops | 0.01 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.23 | 0.43 | 0.39 | 0.34 | 0.31 |
| EPS Diluted Continuous Ops | 0.22 | 0.43 | 0.39 | 0.34 | 0.31 |
| EPS Diluted Discontinuous Ops | 0.01 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $721,200 | $744,300 | $724,900 | $670,938 | $616,609 |